Funding

Researcher : Ane Amundarain Iraola

3 funding - 395,825€

data available since 2020

2022

TERAPIA BASADA EN NANOTRANSPORTADORES DE RNA PARA EL TRATAMIENTO DEL CANCER - NanoRC
143,965.00
Identification of the epigenomic and transcriptomic alterations in the transformation of benign monoclonal gammapathies to symptomatic multiple myeloma.
149,985.00

2020

Deciphering the role of transcription factors as chromatin modulators and drivers of lymphoid neoplasm
101,875.00